Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Hair loss greatly affects women's mental health and appearance satisfaction.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Doctors should consider psychological factors when treating skin conditions and work with mental health experts.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.